Insider trade

Bio Key International (BKYI): CEO received 250 shares

Michael W Depasquale, CEO at Bio Key International, reported a grant / award of 250 shares.

250
Shares · @ $3.83
Traded
Jun 30, 2026
Filed
Jul 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 6, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “ Bid Price Rule ”), as the Company’s closing bid price was not at least $1.00 per share for 10 consecutive business days as of May 4, 2026.”
  2. May 18, 2026Company filing · Form 8-K · ResultsReported its results
  3. Jun 5, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On June 5, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the Listings Qualifications Department of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 with the U.S. Securities and Exchange Commission (the “ SEC ”) as required by Nasdaq Listing Rule 5250(c)(1) (the “ Periodic Report Rule…”

What came next

  1. Jul 2, 2026Company filing · Form 8-K · Auditor changeChanged its auditor“On July 2, 2026, the Audit Committee of the Board of Directors (the “ Audit Committee ”) of BIO-key International, Inc. (the “ Company ”) approved the engagement of M&K CPAS, PLLC (“ M&K ”) as the Company’s independent registered public accounting firm and on July 7, 2026, dismissed Bush & Associates CPA LLC (“ Bush & Associates ”) as the Company’s independent registered public accounting firm.”
  2. Aug 10, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
  3. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
  4. Sep 29, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bio Key International

OQRO holds no insider, Congress, fund or contract record for Bio Key International dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BKYI page.

Other recent filings by Michael W Depasquale, Chief Executive Officer

The full history of Michael W Depasquale, Chief Executive Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Bio Key International (BKYI) insider traded, and how much?

Michael W Depasquale, CEO at Bio Key International, reported a grant / award of 250 shares. At $3.83.

When did it happen, and when was it made public?

Traded: Jun 30, 2026. Filed: Jul 3, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean BKYI stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Bio Key International

Everything OQRO holds on this company is on its BKYI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data